These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24757302)

  • 21. Modeling of antipsychotic-induced metabolic alterations in mice: An experimental approach precluding psychosis as a predisposing factor.
    Singh R; Bansal Y; Sodhi RK; Saroj P; Medhi B; Kuhad A
    Toxicol Appl Pharmacol; 2019 Sep; 378():114643. PubMed ID: 31254565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased dyslipidemia in schizophrenic outpatients using new generation antipsychotics.
    Leitão-Azevedo CL; Guimarães LR; de Abreu MG; Gama CS; Lobato MI; Belmonte-de-Abreu PS
    Braz J Psychiatry; 2006 Dec; 28(4):301-4. PubMed ID: 17242810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder.
    De Hert M; Kalnicka D; van Winkel R; Wampers M; Hanssens L; Van Eyck D; Scheen A; Peuskens J
    J Clin Psychiatry; 2006 Dec; 67(12):1889-96. PubMed ID: 17194266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.
    Melkersson K; Berinder K; Hulting AL
    Neuro Endocrinol Lett; 2011; 32(4):428-36. PubMed ID: 21876517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic-Induced Metabolic Syndrome: A Review.
    Akinola PS; Tardif I; Leclerc J
    Metab Syndr Relat Disord; 2023 Aug; 21(6):294-305. PubMed ID: 37347965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.
    Cohrs S
    CNS Drugs; 2008; 22(11):939-62. PubMed ID: 18840034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotics olanzapine and clozapine increase bone loss in female rats with experimental periodontitis.
    Soares MA; Costa ALA; Silva NLC; Martins AF; Matias DO; Araujo OMO; Lopes RT; Takiya CM; Miranda ALP; Miranda-Alves L; Tributino JLM
    J Periodontal Res; 2023 Apr; 58(2):283-295. PubMed ID: 36575324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome in patients with severe mental illness undergoing psychiatric rehabilitation receiving high dose antipsychotic medication.
    Ravindranath BV
    Indian J Psychol Med; 2012 Jul; 34(3):247-54. PubMed ID: 23439746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective study.
    Tschoner A; Engl J; Rettenbacher M; Edlinger M; Kaser S; Tatarczyk T; Effenberger M; Patsch JR; Fleischhacker WW; Ebenbichler CF
    Pharmacopsychiatry; 2009 Jan; 42(1):29-34. PubMed ID: 19153944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice.
    Bodén R; Edman G; Reutfors J; Ostenson CG; Osby U
    Neuropsychiatr Dis Treat; 2013; 9():371-7. PubMed ID: 23682213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study.
    Wampers M; Hanssens L; van Winkel R; Heald A; Collette J; Peuskens J; Reginster JY; Scheen A; De Hert M
    Eur Neuropsychopharmacol; 2012 Jan; 22(1):17-26. PubMed ID: 21511441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic and clinical effect of alpha-lipoic acid administration in schizophrenic subjects stabilized with atypical antipsychotics: A 12-week, open-label, uncontrolled study.
    Iannuzzo F; Basile GA; Campolo D; Genovese G; Pandolfo G; Giunta L; Ruggeri D; Di Benedetto A; Bruno A
    Curr Res Pharmacol Drug Discov; 2022; 3():100116. PubMed ID: 35992380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
    Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
    Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
    Bernardo M; Rico-Villademoros F; García-Rizo C; Rojo R; Gómez-Huelgas R
    Adv Ther; 2021 May; 38(5):2491-2512. PubMed ID: 33826090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial.
    Gupta B; Chee KS; Neo LQ; Tang C; Hariram J; Tan GC; Verma S; Basu S; Appan DP; Ting CC; Abdin E; Lee J
    Ther Adv Psychopharmacol; 2021; 11():20451253211046765. PubMed ID: 34646440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.